Changed Date For Biovitrum (STO:BVT) 's Year-end Report 2008

Biovitrum (STO:BVT) The Biovitrum AB (publ) 2008 year-end report reporting date has been changed. The report will be published Tuesday February 10, 2009.



About Biovitrum Biovitrum is a Swedish pharmaceutical company. The company markets a range of specialist pharmaceuticals internationally. Using its expertise and experience Biovitrum takes scientific innovation all the way to the market and to specialist indication patients with significant medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics. The company has revenues of approximately SEK 1.3 billion and around 500 employees. It is listed on the OMX Nordic Exchange in Stockholm. For more information go to www.biovitrum.com.

For further information, please contact

Göran Arvidson, CFO Cell phone: +46 70 633 30 42

Erik Kinnman, VP Investor Relations Cell phone: +46 73 422 15 40 erik.kinnman@biovitrum.com

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



LINK: http://hugin.info/134557/R/1284380/287773.pdf

Biovitrum

http://www.biovitrum.com

ISIN: SE0000872095

Stock Identifier: XOME.BVT